This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
The BMS IDO1 inhibitor, BMS-986242, is a clinical candidate in a Ph. I/II study in combination with nivolumab for cancer.…
molecule
2 years ago ●
1 min read
The CellCentric p300/CBP inhibitor, CCS1477, is an orally available drug in early development for advanced prostate cancer, and is structurally…
molecule
2 years ago ●
1 min read
The academic covalent ALKi inhibitor, Con B-1, is thought-provoking initial proof-of-concept that remote kinase cysteines might be targetable from an…
molecule
2 years ago ●
1 min read
Novo oral insulin analog
molecule
2 years ago ●
1 min read
Pfizer noncovalent oral hemoglobin (HbS) modulator
molecule
2 years ago ●
1 min read
AstraZeneca oral reversible ERK1/2 kinase inhibitor
molecule
2 years ago ●
1 min read
Load More
